JOHN JASINSKI: Open Payments
NPI 1598781791 · NORWALK, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$64,535 in 362 payments from 21 companies in 2025. Trend: 2023 $36,589 · 2024 $48,627 · 2025 $64,535
Speaker / faculty: $50,668Food & beverage: $7,576Travel & lodging: $3,632Consulting: $2,580Education: $80
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 54 | $19,690 |
| ABBVIE INC. | 81 | $15,209 |
| Incyte Corporation | 46 | $11,812 |
| UCB, Inc. | 33 | $11,729 |
| GENZYME CORPORATION | 24 | $2,239 |
| Regeneron Pharmaceuticals, Inc. | 4 | $1,449 |
| Regeneron Healthcare Solutions, Inc. | 26 | $516 |
| LEO Pharma Inc. | 23 | $393 |
| Novartis Pharmaceuticals Corporation | 7 | $237 |
| Organon LLC | 7 | $220 |
Products named: TREMFYA, RINVOQ, Bimzelx, OPZELURA, DUPIXENT, SKYRIZI, ADBRY, Sotyktu.
Industry payments across CT — which companies pay providers there.
